1042 related articles for article (PubMed ID: 15590442)
1. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
Nasseri F; Mamouri GA; Babaei H
Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease.
Figueras-Aloy J; Rodríguez-Miguélez JM; Iriondo-Sanz M; Salvia-Roiges MD; Botet-Mussons F; Carbonell-Estrany X
Pediatrics; 2010 Jan; 125(1):139-44. PubMed ID: 19948572
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rate of ABO hemolytic disease of the newborn.
Katz MA; Kanto WP; Korotkin JH
Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of early interventions for ABO hemolytic disease of the newborn].
Huang WM; Chen HW; Li N; Yang M; Jiao PY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1350-1, 1355. PubMed ID: 16982453
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases.
Singhal PK; Singh M; Paul VK; Deorari AK; Ghorpade MG
Indian Pediatr; 1992 Mar; 29(3):319-25. PubMed ID: 1612673
[TBL] [Abstract][Full Text] [Related]
9. Review of positive direct antiglobulin tests found on cord blood sampling.
Dinesh D
J Paediatr Child Health; 2005; 41(9-10):504-7. PubMed ID: 16150068
[TBL] [Abstract][Full Text] [Related]
10. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?
Yaseen H; Khalaf M; Rashid N; Darwich M
J Perinatol; 2005 Sep; 25(9):590-4. PubMed ID: 16034477
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
[TBL] [Abstract][Full Text] [Related]
12. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
Ceccon ME; Diniz EM; Ramos JL; Vaz FA
Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
Mundy CA
Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
[TBL] [Abstract][Full Text] [Related]
15. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)].
Fischer K; Poschmann A; Grundmann A
Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177
[TBL] [Abstract][Full Text] [Related]
16. ABO hemolytic disease: a comparative study of clinical severity and delayed anemia.
Kanto WP; Marino B; Godwin AS; Bunyapen C
Pediatrics; 1978 Sep; 62(3):365-9. PubMed ID: 568235
[TBL] [Abstract][Full Text] [Related]
17. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
18. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
Senterre T; Minon JM; Rigo J
Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
[TBL] [Abstract][Full Text] [Related]
19. [Icterus gravis and exchange transfusion].
Tulzer W; Griebler T
Wien Med Wochenschr; 1967 Apr; 117(13):334-7. PubMed ID: 4968441
[No Abstract] [Full Text] [Related]
20. Severe hemolytic disease of the newborn caused by anti-Gonzales antibody.
Leschek E; Pearlman SA; Boudreaux I; Meek R
Am J Perinatol; 1993 Sep; 10(5):362-4. PubMed ID: 8240594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
